Literature DB >> 7774724

Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1.

M Gu1, J Rappaport, S H Leppla.   

Abstract

The envelope glycoproteins of HIV are required for viral infectivity. Proteolysis of the precursor envelope glycoprotein gp160 results in the formation of gp120 and gp41. Cleavage occurs after the sequence Arg-Glu-Lys-Arg. This sequence is expected to be a substrate for the cellular protease furin. We examined whether furin is responsible for cleavage of gp160 by using a furin-deficient CHO cell line and the same cell line transfected with furin cDNA. Data obtained from viral transmission assays suggested that furin increased viral infectivity but was not essential for the maturation of gp160, implying that other proprotein processing enzymes also recognize this putative furin cleavage site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774724     DOI: 10.1016/0014-5793(95)00447-h

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.

Authors:  Celine Deraison; Chrystelle Bonnart; Frederic Lopez; Celine Besson; Ross Robinson; Arumugam Jayakumar; Fredrik Wagberg; Maria Brattsand; Jean Pierre Hachem; Goran Leonardsson; Alain Hovnanian
Journal:  Mol Biol Cell       Date:  2007-06-27       Impact factor: 4.138

3.  Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

4.  PACE4: a subtilisin-like endoprotease with unique properties.

Authors:  R E Mains; C A Berard; J B Denault; A Zhou; R C Johnson; R Leduc
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region.

Authors:  L Van Rompaey; T Ayoubi; W Van De Ven; P Marynen
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion.

Authors:  Yufei Long; Fanxia Meng; Naoyuki Kondo; Aikichi Iwamoto; Zene Matsuda
Journal:  Protein Cell       Date:  2011-06-12       Impact factor: 14.870

7.  Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.

Authors:  Eri Nakatani-Webster; Shiu-Lok Hu; William M Atkins; Carlos Enrique Catalano
Journal:  J Virol Methods       Date:  2015-09-28       Impact factor: 2.014

8.  Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases.

Authors:  F Vollenweider; S Benjannet; E Decroly; D Savaria; C Lazure; G Thomas; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

9.  Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.

Authors:  V Cheynet; A Ruggieri; G Oriol; J-L Blond; B Boson; L Vachot; B Verrier; F-L Cosset; F Mallet
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

10.  The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.

Authors:  Kosuke Miyauchi; A Rachael Curran; Yufei Long; Naoyuki Kondo; Aikichi Iwamoto; Donald M Engelman; Zene Matsuda
Journal:  Retrovirology       Date:  2010-11-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.